Literature DB >> 106066

Hyperprolactinemia and impaired pituitary response to suppression and stimulation in chronic renal failure: reversal after transplantation.

V S Lim, S C Kathpalia, L A Frohman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 106066     DOI: 10.1210/jcem-48-1-101

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  19 in total

Review 1.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

Review 2.  Hormonal derangements in uremia.

Authors:  G Tolis; D Goltzman; H Guyda; T Mountokalakis
Journal:  J Endocrinol Invest       Date:  1980 Jan-Mar       Impact factor: 4.256

3.  Diagnostic value of thyrotropin-releasing-hormone stimulation in patients with pituitary tumor.

Authors:  D M Cook; M A Greer; H Paxton
Journal:  West J Med       Date:  1987-08

4.  Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis.

Authors:  Joan C Lo; Gerald J Beck; George A Kaysen; Christopher T Chan; Alan S Kliger; Michael V Rocco; Glenn M Chertow
Journal:  Hemodial Int       Date:  2016-10-23       Impact factor: 1.812

Review 5.  Control of prolactin secretion.

Authors:  G Benker; C Jaspers; G Häusler; D Reinwein
Journal:  Klin Wochenschr       Date:  1990-12-04

6.  Altered growth hormone response after growth hormone releasing hormone administration in chronic renal failure.

Authors:  R V Garcia; A Andrade; J Perez; M Courel; F F Casanueva
Journal:  J Endocrinol Invest       Date:  1991-05       Impact factor: 4.256

Review 7.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

8.  Effect of 1,25-dihydroxyvitamin D3 on plasma prolactin in patients with renal failure on regular dialysis treatment.

Authors:  D Verbeelen; L Vanhaelst; A C Van Steirteghem; J Sennesael
Journal:  J Endocrinol Invest       Date:  1983-10       Impact factor: 4.256

Review 9.  Hyperprolactinemia.

Authors:  Jaspreet Chahal; Janet Schlechte
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

10.  Lack of dissociation of prolactin responses to thyrotropin releasing hormone and metoclopramide in chronic alcoholic men.

Authors:  D H Van Thiel; J S Gavaler; A Sanghvi
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.